PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Небольшая подборка полезной литературы

Опубликовано 6 марта, 201930 июня, 2019 frozencat

Data And Safety Monitoring Committees In Clinical Trials

Epidemiology and Biostatistics An Introduction to Clinical Research

Statistical Methods for Survival Trial Design: With Applications to Cancer Clinical Trials Using R

Clinical trial data analysis with R and SAS

Clinical Trials Design in Operative and Non Operative Invasive Procedures

Analyzing Longitudinal Clinical Trial Data: A Practical Guide

Bioequivalence and Statistics in Clinical Pharmacology, Second Edition

Design and Analysis of Bioavailability and Bioequivalence Studies

Biomaterials in Clinical Practice : Advances in Clinical Research and Medical Devices

Fundamental Statistical Inference A Computational Approach

Statistics and Simulation

Medical biostatistics

Biostatistics

Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development

Biosimilar Clinical Development: Scientific Considerations and New Methodologies

Рубрики: Блог, Общее

Навигация по записям

Предыдущая запись: Расчет доверительных интервалов для 2X2 биоэквивалентности: Julia concept code
Следующая запись: Протокол и отчет клинического исследования биоэквивалентности: шаблон

Свежие записи

  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0

Галерея

20180131 135949
20170730 121344
DJI 0025
20180130 144816
20180202 124428
20180202 160102
  • Human medicines European public assessment report (EPAR): Actelsar HCT, telmisartan,hydrochlorothiazide, Date of authorisation: 13/03/2013, Revision: 19, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-05-13
  • Human medicines European public assessment report (EPAR): Enbrel, etanercept, Date of authorisation: 02/02/2000, Revision: 75, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-05-13
  • Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Revision: 2, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-05-13
  • Compounding Quality Center of Excellence | Engage with the Compounding Quality Center of Excellence
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-05-13 By FDA
  • Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Date of authorisation: 04/04/2025, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-05-13
  • IXCHIQ
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-05-13 By FDA
  • Tissue Guidances
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-05-12 By FDA
  • Allergenics
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-05-12 By FDA
  • eSubmitter Application History
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-05-12 By FDA
  • Development & Approval Process (CBER)
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-05-12 By FDA
  • Untitled Letters
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-05-12 By FDA
  • FDA and CDC Recommend Pause in Use of Ixchiq (Chikungunya Vaccine, Live) in Individuals 60 Years of Age and Older While Postmarketing Safety Reports are Investigated: FDA Safety Communication
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-05-12 By FDA
  • Human medicines European public assessment report (EPAR): Xyrem, sodium oxybate, Date of authorisation: 13/10/2005, Revision: 37, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-05-12
  • GDUFA Type II API DMF Payment Receipts Report
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-05-12 By FDA
  • Human medicines European public assessment report (EPAR): Dimethyl fumarate Mylan, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 2, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-05-12
Предыдущие записи
Тема: Scaffold от Danny Cooper.